Condition
Mesothelioma
Estimated Enrollment: 1000
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Case-Only|Time Perspective: Cross-Sectional
Study ID Numbers: GTS 36076 MARF
Study First Received: April 23, 2012
Last Updated: July 9, 2014
Estimated Primary Completion Date: December 2014
Primary Outcome Measures:
Creation of a consortium of investigators (6 sites) for collection of blood for germline DNA and demographic information from 1000 mesothelioma subjects.|GWAS will be performed on the DNA from the 1000 subjects with mesothelioma and compared with 1000 age and asbestos exposure matched controls free of past personal history and family history of cancer.
Sponsors and Collaborators:
Wake Forest University Health Sciences|University of Pennsylvania|Mayo Clinic|New York University School of Medicine|Johns Hopkins University|Memorial Sloan Kettering Cancer Center|Mesothelioma Applied Research Foundation, Inc.
Website Link: https://ClinicalTrials.gov/show/NCT01590472
